Last updated: 2 December 2019 at 8:30pm EST

Michael P. Cooke Net Worth




The estimated Net Worth of Michael P. Cooke is at least $823 Thousand dollars as of 2 December 2019. Michael Cooke owns over 7,500 units of Magenta Therapeutics Inc stock worth over $168,366 and over the last 6 years Michael sold MGTA stock worth over $654,350.

Michael Cooke MGTA stock SEC Form 4 insiders trading

Michael has made over 10 trades of the Magenta Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Michael sold 7,500 units of MGTA stock worth $97,500 on 2 December 2019.

The largest trade Michael's ever made was selling 7,500 units of Magenta Therapeutics Inc stock on 2 December 2019 worth over $97,500. On average, Michael trades about 4,375 units every 14 days since 2018. As of 2 December 2019 Michael still owns at least 240,523 units of Magenta Therapeutics Inc stock.

You can see the complete history of Michael Cooke stock trades at the bottom of the page.



What's Michael Cooke's mailing address?

Michael's mailing address filed with the SEC is 50 Hampshire St, Cambridge, MA 02139, USA.

Insiders trading at Magenta Therapeutics Inc

Over the last 6 years, insiders at Magenta Therapeutics Inc have traded over $6,775,591 worth of Magenta Therapeutics Inc stock and bought 1,257,000 units worth $10,105,000 . The most active insiders traders include Bruce Booth, Rock Ventures Iv, L.P.Third..., and Jeffrey W. Albers. On average, Magenta Therapeutics Inc executives and independent directors trade stock every 46 days with the average trade being worth of $99,614. The most recent stock trade was executed by Rock Ventures Iv, L.P.Third... on 7 February 2023, trading 3,700,000 units of MGTA stock currently worth $3,071,000.



What does Magenta Therapeutics Inc do?

magenta therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases. by creating a platform focused on key areas of transplant medicine, magenta therapeutics is pioneering an integrated, but modular approach to stem cell therapies that reboot the blood and immune systems to create patient benefit. founded by internationally recognized leaders in stem cell transplant medicine, magenta therapeutics was launched in 2016 by third rock ventures and atlas venture and is headquartered in cambridge, mass. for more information, please visit www.magentatx.com.



Complete history of Michael Cooke stock trades at Magenta Therapeutics Inc

Insider
Trans.
Transaction
Total value
Michael P. Cooke
Chief Scientific Officer
Sale $97,500
2 Dec 2019
Michael P. Cooke
Chief Scientific Officer
Sale $60,000
20 Nov 2019
Michael P. Cooke
Chief Scientific Officer
Sale $53,350
1 Nov 2019
Michael P. Cooke
Chief Scientific Officer
Sale $50,050
1 Oct 2019
Michael P. Cooke
Chief Scientific Officer
Sale $19,872
19 Sep 2019
Michael P. Cooke
Chief Scientific Officer
Sale $10,128
12 Sep 2019
Michael P. Cooke
Chief Scientific Officer
Sale $50,550
3 Sep 2019
Michael P. Cooke
Chief Scientific Officer
Sale $100,650
1 Aug 2019
Michael P. Cooke
Chief Scientific Officer
Sale $108,000
1 Jul 2019
Michael P. Cooke
Chief Scientific Officer
Sale $104,250
17 Jun 2019


Magenta Therapeutics Inc executives and stock owners

Magenta Therapeutics Inc executives and other stock owners filed with the SEC include: